China Medical System Holdings Limited (HKG:0867)
13.09
+0.03 (0.23%)
Apr 28, 2026, 4:08 PM HKT
HKG:0867 Market Cap
HKG:0867 has a market cap or net worth of 31.61 billion as of April 28, 2026. Its market cap has increased by 63.52% in one year.
Market Cap
31.61B
Enterprise Value
26.10B
Revenue
9.14B
Ranking
n/a
PE Ratio
19.07
Stock Price
13.09
Market Cap Chart
Since September 28, 2010, HKG:0867's market cap has increased from 6.34B to 31.61B, an increase of 398.80%. That is a compound annual growth rate of 10.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 31.61B | 1.41% |
| Dec 31, 2025 | 31.17B | 70.86% |
| Dec 31, 2024 | 18.24B | -46.24% |
| Dec 29, 2023 | 33.94B | 12.70% |
| Dec 30, 2022 | 30.11B | -5.89% |
| Dec 31, 2021 | 32.00B | 49.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Resources Pharmaceutical Group | 36.31B |
| Simcere Pharmaceutical Group | 32.60B |
| Sunshine Lake Pharma | 24.18B |
| Grand Pharmaceutical Group | 22.97B |
| The United Laboratories International Holdings | 19.43B |
| Fujian Haixi Pharmaceuticals | 18.70B |
| Consun Pharmaceutical Group | 13.33B |
| CanSino Biologics | 12.95B |